Hugo GambleHugo Gamble
|
 |
"HIV mutations are a serious home testing kits problem. Participants order the kits online, test themselves at home, mail a tiny blood sample to BioIQ's lab, and then view test results through secure, password-protected accounts. /cgi-bin/prnh/20080826/LATU074) In addition to providing QAD employees and their dependents with a user-friendly kit to screen for diabetes and heart disease, the BioIQ service enables them to discover disease risk factors via an interactive home testing kits health assessment. PLEASANTON, Calif., / / -- Roche announced today that its innovative dual-target HIV-1 test has received CE Mark certification, allowing it to be sold for clinical use in the European Union. BioIQ also provides certified health coaches via a toll-free number. This approach provides reliable hiv test test results even when mutations are present. Worldwide, the Group employs about home hiv testing kit 80,000 people. That same year, some 2.5 million people became newly infected, and 2.1 million died of AIDS, assimilating 330,000 children. The test uses Roche's proprietary fully automated real-time PCR technology to quantify the amount of HIV-1 RNA in a patient's blood. The COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) System is flexible and customizable to reach the space and workflow needs of any laboratory. SANTA Shelly, Calif., / urine drug home testing kits diabetes testing kit / -- BioIQ /), a leading supplier of health screening and data management services, announced today that QAD, a developer of enterprise resource planning and supply chain software, is offering BioIQ's home test kits to its entire U.S. In 2005, Roche received CE Mark certification for the full viral load monitoring menu (HIV-1, HBV, and HCV) on the system. The human immunodeficiency virus (HIV) is a retrovirus that infects cells diabetes test of the human immune system, destroying or impairing their function. As the world's biggest biotech crew and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. In 2007 sales by the Pharmaceuticals Division totaled 36.8 billion Swiss francs, and the Diagnostics Division posted sales of 9.3 billion francs. Roche has R&D agreements and strategic alliances home test hiv with numerous partners, including majority ownership interests in Genentech and Chugai, and invested over 8 billion Swiss francs in R&D in 2007. The test is highly sensitive and can detect the World Health Organization HIV-1 RNA Standard in EDTA plasma as low as 20 copies per milliliter of patient sample. Using the latest biometric testing technologies and powered by BioIQ's web-based data analysis and reporting software, QAD laboratory drug testing kits is offering the BioIQ health screening program to more than 600 people in 38 states. About HIV-1 According to estimates by the World Health Organization (WHO) and UNAIDS, 33.2 million people were living with HIV at the end of 2007. Because it is impossible to predict when these mutations will occur, we have designed this test to detect all HIV-1 (Group M and O) strains," said Sigfrid O'Day, President and CEO of Roche Molecular Diagnostics. The standard can also accurately quantify the amount of HIV in a patient sample up to 10 million copies/mL representing a broader dynamic range than previous generation tests. The COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) HIV-1 Test, v2.0 utilizes a unique design to simultaneously amplify and detect two separate regions of the HIV-1 genome. The ability of HIV to mutate itself in the presence of antiretroviral drugs can lead to treatment failure, increased direct and indirect health costs associated with the need to start more expensive second-line treatment for patients, the spread of resistant strains of HIV and the need to develop new anti-HIV drugs.(1) About Roche and the Roche Diagnostics Division Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. The test is designed for use on the fully automated, real-time PCR platform, providing sample-in/results-out capability. Within 10-15 years an HIV infection will develop into acquired immunodeficiency syndrome (AIDS); antiretroviral drugs can slow down this process even further. About the COBAS(R) AmpliPrep/COBAS(R) TaqMan(R) Expanding universe The COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) HIV Test, v2.0 is the first dual-target test to be offered on the COBAS(R) AmpliPrep / COBAS(R) TaqMan(R) Frame of reference. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. In the early stages of infection, the person has no symptoms. "This innovative fully-automated solution will provide reliable results for laboratories and physicians to more confidently and efficiently treat HIV-1 patients undergoing therapy." It is critical for viral load monitoring tests to be able to quantify very low and high levels of virus, an indicator of the need for more or less aggressive treatment. All trademarks used or mentioned in this release are legally protected by law. HIV is transmitted through unprotected sexual intercourse (anal or vaginal), transfusion of contaminated blood, sharing of contaminated needles, and between a mother and her infant during pregnancy, childbirth and breastfeeding. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous sight.
|